KYORIN Pharmaceutical Co., Ltd. (TSE: 4569)
Health Care · Pharmaceuticals · JP
¥1,055.00
-0.94% today · -26.9% 1Y
KYORIN Pharmaceutical Co., Ltd. (TSE: 4569) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $382.76M and employs 1,982 people.
Over the last twelve months the share price has lost 26.9%, trading between 1.05K and 1.73K.
Tweenvest scores KYORIN Pharmaceutical Co., Ltd. across four factors: quality 74/100, value 44/100, growth 15/100, dividend 88/100. Its strongest factor is dividend.
4569 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $382.76M
- Revenue (TTM)
- $773.21M
- P/E
- 27.90
- EPS
- 37.81
- Dividend yield
- 2.37%
- Beta (5Y)
- -0.02
- 52-week high
- ¥1,725.00
- 52-week low
- ¥1,046.00
- Avg volume (3M)
- —
- Shares outstanding
- 57.45M
- Employees
- 1,982
- Next earnings
- —
About KYORIN Pharmaceutical Co., Ltd.
Based in Tokyo, Japan, and founded in 1923, KYORIN Holdings, Inc. is a pharmaceutical enterprise engaged in the discovery, development, production, and worldwide distribution of both innovative prescription drugs and generic equivalents. Its diverse therapeutic catalog features medications such as Flutiform for asthma; Desalex, an antiallergic agent; and treatments like Beova, Uritos, and Imidafenacin KYORIN for overactive bladder. The company also offers Lasvic, a quinolone antibacterial; Pentasa for managing ulcerative colitis and Crohn's disease; Nasonex and Kipres for allergic rhinitis; and Mucodyne, a mucoregulating compound. Further pharmaceutical products include Montelukast KM, prescribed for bronchial asthma and allergic rhinitis. Beyond drugs, KYORIN Holdings markets specialized items like the GeneSoC real-time PCR system, disinfectant solutions such as Rubysta and Milton, over-the-counter remedies, diagnostic tools, industrial chemicals, and various reagents and intermediates. The company extends its services to include contract drug manufacturing and actively participates in early-stage research, including identifying and assessing candidate compounds, analyzing competitor technologies, and collecting data from clinical trials.
- ISIN
- JP3247090008
- Founded
- 1923
- Listed since
- Jan 4, 2001
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shandong Sito Bio-technology Co., Ltd.SZSE: 300583 | $394.52M | CN¥13.93 | +1.68% |
| Aarti Drugs LimitedBSE: 524348 | $389.58M | Rs413.10 | -2.12% |
| Foresee Pharmaceuticals Co., Ltd.TPEX: 6576 | $385.29M | NT$78.20 | -1.01% |
| Unichem Laboratories LimitedBSE: 506690 | $385.27M | Rs529.60 | -1.10% |
| Kwality Pharmaceuticals LimitedBSE: 539997 | $381.97M | Rs3,562.70 | -0.27% |
| Verano Holdings Corp.CNSX: VRNO | $381.78M | CA$7.44 | -0.67% |
| Shinpoong Pharmaceutical Co.,LtdKOSE: A019170 | $375.67M | ₩9,780.00 | +5.73% |
| Honz Pharmaceutical Co., Ltd.SZSE: 300086 | $373.04M | CN¥5.49 | +2.23% |
Figures last refreshed Oct 11, 2026.